Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1035083.RADtPOJ0UR0aTpYRW-M8KAgT_J10gI0keMGWz8ioDaD6g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1035083.RADtPOJ0UR0aTpYRW-M8KAgT_J10gI0keMGWz8ioDaD6g130_assertion type Assertion NP1035083.RADtPOJ0UR0aTpYRW-M8KAgT_J10gI0keMGWz8ioDaD6g130_head.
- NP1035083.RADtPOJ0UR0aTpYRW-M8KAgT_J10gI0keMGWz8ioDaD6g130_assertion description "[Finally, expression of constitutive activate MKK6 or HA-p38 MAPK vectors in lung cancer cells was able to abrogate ERCC1 downregulation by metformin and paclitaxel as well as cell viability and DNA repair capacity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1035083.RADtPOJ0UR0aTpYRW-M8KAgT_J10gI0keMGWz8ioDaD6g130_provenance.
- NP1035083.RADtPOJ0UR0aTpYRW-M8KAgT_J10gI0keMGWz8ioDaD6g130_assertion evidence source_evidence_literature NP1035083.RADtPOJ0UR0aTpYRW-M8KAgT_J10gI0keMGWz8ioDaD6g130_provenance.
- NP1035083.RADtPOJ0UR0aTpYRW-M8KAgT_J10gI0keMGWz8ioDaD6g130_assertion SIO_000772 23228696 NP1035083.RADtPOJ0UR0aTpYRW-M8KAgT_J10gI0keMGWz8ioDaD6g130_provenance.
- NP1035083.RADtPOJ0UR0aTpYRW-M8KAgT_J10gI0keMGWz8ioDaD6g130_assertion wasDerivedFrom befree-2016 NP1035083.RADtPOJ0UR0aTpYRW-M8KAgT_J10gI0keMGWz8ioDaD6g130_provenance.
- NP1035083.RADtPOJ0UR0aTpYRW-M8KAgT_J10gI0keMGWz8ioDaD6g130_assertion wasGeneratedBy ECO_0000203 NP1035083.RADtPOJ0UR0aTpYRW-M8KAgT_J10gI0keMGWz8ioDaD6g130_provenance.